Severe Acro-osteolysis in a Case of Limited Cutaneous Scleroderma
Abstract
Please provide alternate text for this image to ensure accessibility for users with text-only browsers or assistive devices.
Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, et al (2015). Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis, 74(4):730-7.
Parish LC, Brenner S, Parish JL, Ramos-e-Silva M (2010). Manual of Gender Dermatology. Jones & Bartlett Learning.
Firestein GS, Kelley WN, Budd RC, Gabriel SE, McInnes IB, O'Dell JR (2013). Kelley's textbook of rheumatology. 9th ed. Elsevier Health Sciences.
Mayes MD (2003). Scleroderma epidemiology. Rheum Dis Clin North Am, 29(2):239-54.
Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al (2003). Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum, 48(8):2246-55.
Kumar MH, Kumar MS, Kumar SH, Kumar KS (2016). A neoteric multidrug combination: novel approach to limited cutaneous systemic scleroderma involving the face. BMJ Case Rep, 2016: bcr2015212787.
Thonhofer R, Siegel C (2009). Extensive calcinosis cutis in limited cutaneous scleroderma. J Rheumatol, 36(12):2834-5.
Callan M (2012). The Rheumatology Handbook. Imperial College Press.
Saad WE, Khaja M, Vedantham S (2015). Vascular and Interventional Imaging. Elsevier.
McCray CJ, Mayes MD (2015). Update on systemic sclerosis. Curr Allergy Asthma Rep, 15(5):25.
| Files | ||
| Issue | Vol 46 No 1 (2017) | |
| Section | Letter to the Editor | |
| Keywords | ||
| No keywords## | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
